Skip to content
KR
EN
Open Whole Menu
About Company
- Overview
- Mission
- Subsidiary
Sustainable management
Financial Highlight
- Financial informationt
PR center
- PR center
Close Whole Menu
HOME > PR center > PR center
PR센터 목록 테이블
No
Title
Date
68
SK D&D signs MOU with the largest global co-living provider Habyt to strengthen residential business
24.04.16
67
SK chemicals Exceeds KRW 600 Billion in Cumulative Sales for Osteoarthritis Treatment “Joins”
24.04.08
66
"Recognition for Efforts in Climate Change Response and Water Resource Protection" SK chemicals receives Honors Award at 2023 CDP Korea Awards
24.04.08
65
SK chemicals Achieves Upgraded “AA” MSCI ESG Rating
24.04.08
64
SK Chemicals Targets the US Medical Packaging Market with Circular Recycling Solution
24.02.01
63
SK chemicals, First in Domestic Chemical Industry to Obtain SBTi Greenhouse Gas Reduction Target Approval
24.01.11
62
Administration of Novavax’s Updated COVID-19 Vaccine Will Begin in Korea on December 18
23.12.12
61
SK bioscience and Sanofi Initiate Submission of Phase III Study Investigational New Drug Amendment to the U.S. FDA of 21-Valent Pneumococcal Conjugate Vaccine Candidate
23.12.11
60
SK bioscience Expands L HOUSE for Preparing Commercialization of Next-Generation Pneumococcal Vaccine
23.11.28
59
SK bioscience and Hilleman Laboratories Announce Joint Development of Second -Generation Zaire Ebola Virus Vaccine
23.11.22
이전 페이지
1
2
3
4
5
다음 페이지